CMS Proposes Changes For Outpatient Device Pass-Through Payments
This article was originally published in The Gray Sheet
Executive Summary
The Medicare agency wants to bring the process for awarding pass-through bonus payments to devices in the hospital outpatients more into the light of day, and also add criteria to ensure only devices approved within the prior three years can qualify. The proposals were made in the 2016 Medicare outpatient payment proposed rule.
You may also be interested in...
Medicare Add-On Payments Granted For Cardiac, Neuro Devices
CMS agreed to grant new tech add-on payments to St. Jude’s CardioMEMS implantable heart failure monitoring system and Abbott’s MitraClip mitral valve repair system, but it took some convincing. The agency also granted an add-on for NeuroPace’s RNS responsive neurostimulator system to treat seizures.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.